Arnold Oronsky Insider Profile
4 Followers
Arnold Oronsky, Director, Ten Percent Owner at PMV Pharmaceuticals, holds 6.47M shares in PMV Pharmaceuticals (Ticker: PMVP), holds 388.77K shares in KalVista Pharmaceuticals (Ticker: KALV), holds 2.48K shares in Tesaro (Ticker: TSRO).
Arnold Oronsky's Trading History
| PMVPPMV Pharmaceuticals | Sep 29, 2020 | Director, Ten Percent Owner | Uninformative Buy | ― | $7.70M | |
| KALVKalVista Pharmaceuticals | Sep 12, 2018 | ― | Informative Buy | 1.00M | $10.50M | |
| TSROTesaro | Jun 05, 2017 | ― | Uninformative Buy | ― | $185.83K | |
| AGTCApplied Genetic Technologies | Apr 26, 2017 | ― | Uninformative Buy | 53.88K | $570.72K | |
| MGNXMacroGenics | Feb 18, 2014 | Director | Informative Sell | 7.30M | $3.71M | |
| DVAXDynavax | Oct 30, 2013 | ― | Informative Buy | 199.07K | $6.39M |
You May Also Like
Arnold Oronsky insider profile FAQ
What is the percentage of profitable transactions made by Arnold Oronsky?
The percentage of profitable transactions made by Arnold Oronsky is 40%.
What is the average return per transaction made by Arnold Oronsky?
The average return per transaction made by Arnold Oronsky is 46.80%.
What stocks does Arnold Oronsky hold?
Arnold Oronsky holds: PMVP, TSRO, KALV, AGTC, DVAX, MGNX stocks.
What was Arnold Oronsky's most profitable transaction?
Arnold Oronsky’s most profitable transaction was an Informative Buy of TSRO stock on March 18, 2016. The return on the trade was 230.40%.
What is Arnold Oronsky's role in PMV Pharmaceuticals?
Arnold Oronsky's role in PMV Pharmaceuticals is Director, Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.
